|
| 產(chǎn)地 | 進(jìn)口、國產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號 | CS10205 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號 | |
| 抗體名 | Anti-phosphos-PCNA (Tyr211) |
| 克隆性 | |
| 靶點 | 詳見說明書 |
| 適應(yīng)物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標(biāo)識物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated Synthesised phosphopeptide derived from human PCNA around the phosphorylation site of Tyr211 |
全、新、優(yōu)、品、好四大特點：
磷酸化增殖細(xì)胞核抗原抗體費用 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。
磷酸化增殖細(xì)胞核抗原抗體費用 英文名稱 Anti-phosphos-PCNA (Tyr211)
中文名稱 磷酸化增殖細(xì)胞核抗原抗體費用
別 名 PCNA(Tyr211); PCNA; Cyclin; DNA polymerase delta auxiliary protein; HGCN8729; MGC8367; Mutagen-sensitive 209 protein; Pcna/cyclin; PCNAR; Polymerase delta accessory protein; Proliferating Cell Nuclear Antigen; PCNA_HUMAN.
產(chǎn)品屬性：
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Chicken, Cow, Rabbit, Sheep
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 細(xì)胞凋亡 轉(zhuǎn)錄調(diào)節(jié)因子 細(xì)胞類型標(biāo)志物
蛋白分子量 predicted molecular weight: 29kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human PCNA around the phosphorylation site of Tyr211
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
磷酸化增殖細(xì)胞核抗原抗體費用 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Proliferation Marker
Proliferating cell nuclear antigen (PCNA) is a 28kDa nuclear protein associated with the cell cycle, a nuclear protein vital for cellular DNA synthesis. Proliferating cell nuclear antigen was originally identified by immunofluorescence as a nuclear protein whose appearance correlated with the proliferate state of the cell. PCNA is required for replication of DNA in vitro and has been identified as the auxiliary protein (cofactor) for DNA polymerase delta. The anti-PCNA antibodies react with the nuclei of proliferating cells. PCNA is essential for cellular DNA synthesis and is also required for the in vitro replication of simian virus 40 (SV40) DNA where it acts to coordinate leading and lagging strand synthesis at the replication fork. The PCNA protein may fulfil several separate roles in the cell nucleus associated with changes in its antigenic structure.
Function : Auxiliary protein of DNA polymerase delta and is involved in the control of eukaryotic DNA replication by increasing the polymerase's processibility during elongation of the leading strand. Induces a robust stimulatory effect on the 3'-5' exonuclease and 3'-phosphodiesterase, but not apurinic-apyrimidinic (AP) endonuclease, APEX2 activities. Has to be loaded onto DNA in order to be able to stimulate APEX2. Plays a key role in DNA damage response (DDR) by being conveniently positioned at the replication fork to coordinate DNA replication with DNA repair and DNA damage tolerance pathways. Acts as a loading platform to recruit DDR proteins that allow completion of DNA replication after DNA damage and promote postreplication repair: Monoubiquitinated PCNA leads to recruitment of translesion (TLS) polymerases, while 'Lys-63'-linked polyubiquitination of PCNA is involved in error-free pathway and employs recombination mechanisms to synthesize across the lesion.
Subunit : Homotrimer (By similarity). Forms a complex with activator 1 heteropentamer in the presence of ATP. Interacts with EXO1, POLH, POLK, DNMT1, ERCC5, FEN1, CDC6 and POLDIP2. Interacts with APEX2; this interaction is triggered by reactive oxygen species and increased by misincorporation of uracil in nuclear DNA. Forms a ternary complex with DNTTIP2 and core histone. Interacts with KCTD10 and PPP1R15A (By similarity). Interacts with POLD1, POLD3 and POLD4. Interacts with BAZ1B; the interaction is direct. Interacts with HLTF and SHPRH. Interacts with NUDT15. Interaction is disrupted in response to UV irradiation and acetylation. Interacts with CDKN1A/p21(CIP1) and CDT1; interacts via their PIP-box which also recruits the DCX(DTL) complex. Interacts with DDX11. Interacts with EGFR; positively regulates PCNA. Interacts with PARPBP. Interacts (when ubiquitinated) with SPRTN; leading to enhance RAD18-mediated PCNA ubiquitination. Interacts (when polyubiquitinated) with ZRANB3. Interacts with SMARCAD1. Interacts with CDKN1C. Interacts with KIAA0101/PAF15 (via PIP-box).
Post-translational modifications : Following DNA damage, can be either monoubiquitinated to stimulate direct bypass of DNA lesions by specialized DNA polymerases or polyubiquitinated to promote recombination-dependent DNA synthesis across DNA lesions by template switching mechanisms. Following induction of replication stress, monoubiquitinated by the UBE2B-RAD18 complex on Lys-164, leading to recruit translesion (TLS) polymerases, which are able to synthesize across DNA lesions in a potentially error-prone manner. An error-free pathway also exists and requires non-canonical polyubiquitination on Lys-164 through 'Lys-63' linkage of ubiquitin moieties by the E2 complex UBE2N-UBE2V2 and the E3 ligases, HLTF, RNF8 and SHPRH. This error-free pathway, also known as template switching, employs recombination mechanisms to synthesize across the lesion, using as a template the undamaged, newly synthesized strand of the sister chromatid. Monoubiquitination at Lys-164 also takes place in undamaged proliferating cells, and is mediated by the DCX(DTL) complex, leading to enhance PCNA-dependent translesion DNA synthesis. Sumoylated during S phase.
Acetylated in response to UV irradiation. Acetylation disrupts interaction with NUDT15 and promotes degradation.
Phosphorylated. Phosphorylation at Tyr-211 by EGFR stabilizes chromatin-associated PCNA.
Similarity : Belongs to the PCNA family.
Database links : UniProtKB/Swiss-Prot: P12004.1
PCNA(又稱：Cyclin)是一種僅在增殖細(xì)胞中合成或表達(dá)的核內(nèi)多肽，其表達(dá)和合成與細(xì)胞周期有關(guān)。主要表達(dá)于增殖細(xì)胞的S期、G1期和G2初期。
PCNA主要作為判斷各種(包括胃腸道癌腫、、、等)細(xì)胞增殖和其惡性程度的一種指標(biāo).
實驗流程：
正在熱銷的相關(guān)產(chǎn)品：
Human Oncogene Protein p190/bcr-abl ELISA Kit 人癌基因蛋白質(zhì)p190/bcr-ablMulti-class antibodies規(guī)格： 48T
Anti-His tag(CT) 聚組氨酸抗體g標(biāo)簽抗體(C端)Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh MEF2D 肌細(xì)胞特異性增強(qiáng)因子2D抗體 規(guī)格 0.2ml
DDC(Human dopamine decarboxylase) ELISA Kit 人多巴胺脫羧酶 96T
RASA3 英文名稱： Ras-GTP酶激活蛋白3抗體 0.2ml
C1orf183 英文名稱： 1號染色體開放閱讀框183抗體 0.2ml
Anti-His tag(CT) 聚組氨酸抗體g標(biāo)簽抗體(C端)Multi-class antibodies規(guī)格： 0.1ml
VEGF-R1 人內(nèi)皮生長因子受體1Multi-class antibodies規(guī)格： 48T
Anti-COMP/EPD1 軟骨寡聚基質(zhì)蛋白抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh n-Myc 致癌基因n-Myc抗體 規(guī)格 0.1ml
Human high mobility group protein 17,HMG-17 ELISA Kit 人高速泳動蛋白17 96T
Thrombospondin 2 英文名稱： 血小板反應(yīng)蛋白2/凝血酶敏感蛋白2抗體 0.2ml
CRTAC1 英文名稱： 軟骨酸性蛋白1抗體 0.2ml
Anti-COMP/EPD1 軟骨寡聚基質(zhì)蛋白抗體Multi-class antibodies規(guī)格： 0.2ml
Anti-HIRA/DGGR1/FITC 熒光素標(biāo)記組蛋白替換精蛋白DGGR1抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-phospho-CaMK2a(pTyr231) /FITC 熒光素標(biāo)記兔抗人、大、小鼠等磷酸化鈣/鈣調(diào)素依賴蛋白激酶2α抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh ATRIP/TREX1 相關(guān)蛋白TREX1抗體 規(guī)格 0.2ml
Galanin 神經(jīng)節(jié)肽 0.5mg
GNAQ 英文名稱： G蛋白α亞單位蛋白Q抗體 0.2ml
Rhesus antibody Rh Rabbit anti-mouse Kappa Chain whole serum 兔抗小鼠k-鏈抗血清 規(guī)格 1ml
Anti-phospho-CaMK2a(pTyr231) /FITC 熒光素標(biāo)記兔抗人、大、小鼠等磷酸化鈣/鈣調(diào)素依賴蛋白激酶2α抗體IgGMulti-class antibodies規(guī)格： 0.2ml
大鼠免疫球蛋白A(IgA)ELISA試劑盒 ，英文名： IgA ELISA Kit
人免疫球蛋白M(IgM)ELISA檢測試劑盒HumanImmunoglobulinM,IgMELISAKit 96T/48T
鴨免疫球蛋白E(IgE)免疫試劑盒 Duck Immunoglobulin E,IgE ELISA Kit
CLIAKitforPACAPELISAKit小鼠垂體腺苷酸環(huán)化酶激活肽規(guī)格：48T/96T
水中腸球菌(Eerococci)熒光定量檢測試劑盒20次
ELISAKitCD4人白細(xì)胞分化抗原4規(guī)格：48T/96T
大鼠補體因子H(CFH)ELISA 試劑盒 96T/48T 試劑盒 組裝/原裝
人免疫球蛋白D(IgD)免疫試劑盒 human Immunoglobulin D,IgD ELISA Kit
MouseVascuoarendothelialcellgrowthfactorreceptor2,VEGFR-2/Flk-1ELISAKit小鼠內(nèi)皮細(xì)胞生長因子受體2(VEGFR-2/Flk-1)ELISA試劑盒規(guī)格：96T/48T
石蠟切片組織CASPASE-4蛋白表達(dá)NBT顯色光學(xué)顯微鏡檢測試劑盒10/20次
HumanProstaglandinF2α,PGF2αELISA試劑盒人素F2α(PGF2α)ELISA試劑盒規(guī)格：96T/48T
Humahymosinα1ELISAKit人胸腺肽α1(Thymosinα1)ELISA試劑盒規(guī)格：96T/48T
磷酸化增殖細(xì)胞核抗原抗體費用 大鼠受體相關(guān)蛋白5(LRP5)ELISA試劑盒 ，英文名： LRP5 ELISA Kit
Human FMS like tyrosine kinase 3 ligand (Flt-3L) ELISA Kit 人FMS樣酪氨酸激酶3配體(Flt-3L)ELISA試劑盒
Ratmonocytechemotacticprotein1/monocytechemotacticandactivatingfactor,MCP-1/MCAFELISAkit 大鼠單核細(xì)胞趨化蛋白1(MCP-1/CCL2/MCAF)ELISA試劑盒 96T/48T 進(jìn)口分裝
CLIAKitforCYP450ELISAKit大鼠細(xì)胞色素P450規(guī)格：48T/96T
細(xì)胞色素P450亞酶CYP2B(EFC)活性熒光定量檢測試劑盒20次
RatFollistatin,FSELISAKit大鼠卵泡抑素(FS)ELISA試劑盒規(guī)格：96T/48T
技術(shù)外包服務(wù):
★磷酸化增殖細(xì)胞核抗原抗體費用 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測序、載體構(gòu)建等
★蛋白工程：原核、哺乳動物蛋白表達(dá)系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
|
|
|
|
|
